Guardant Health Has 'Underlying Business Strength' Says This Bullish Analyst
Portfolio Pulse from Priya Nigam
Shares of Guardant Health Inc (NASDAQ:GH) climbed during the premarket trading session and morning on Wednesday. Piper Sandler analyst David Westenberg upgraded the rating for Guardant Health from Neutral to Overweight, establishing a price target of $40. Westenberg believes that despite increasing competition in comprehensive genomic profiling, Guardant Health's strong position in liquid biopsy and potential to generate meaningful data will enable it to hit its 2023 guidance.
September 27, 2023 | 4:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Guardant Health's stock climbed following an upgrade from Piper Sandler analyst David Westenberg. The analyst believes the company's strong position in liquid biopsy and potential to generate meaningful data will enable it to hit its 2023 guidance.
The upgrade from Piper Sandler analyst David Westenberg is a positive signal for Guardant Health. The analyst's bullish outlook on the company's potential in liquid biopsy and ability to generate meaningful data suggests strong future performance, which is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100